Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Rufinamide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,142Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aurobindo's Generic Rufinamide Receives Approval in the U.S.
    Aurobindo's Generic Rufinamide Receives Approval in the U.S.

    16 Jun 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217230

    FDA
    16 Jun 2023
    Share Share
    Eisai Satisfies All-Case Study Requirement For Antiepileptic Agent Inovelon
    Eisai Satisfies All-Case Study Requirement For Antiepileptic Agent Inovelon

    02 Nov 2022

    // EISAI

    https://www.eisai.com/news/2022/news202275.html

    EISAI
    02 Nov 2022
    Share Share
    Aurobindo's Generic Rufinamide Receives Approval in the U.S.
    Aurobindo's Generic Rufinamide Receives Approval in the U.S.

    26 Oct 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216549

    FDA
    26 Oct 2022
    Share Share
    Lupin receives US FDA approval for Rufinamide tablets
    Lupin receives US FDA approval for Rufinamide tablets

    18 Aug 2022

    // EXPRESS PHARMA

    https://www.expresspharma.in/lupin-receives-us-fda-approval-for-rufinamide-tablets/

    EXPRESS PHARMA
    18 Aug 2022
    Share Share
    Lupin's Generic Rufinamide Receives Approval in the U.S.
    Lupin's Generic Rufinamide Receives Approval in the U.S.

    17 Aug 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204964

    FDA
    17 Aug 2022
    Share Share
    Lupin`s Generic Rufinamide Receives Approval In US
    Lupin`s Generic Rufinamide Receives Approval In US

    29 Dec 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213457

    FDA
    29 Dec 2020
    Share Share